28th Oct 2013 10:17
LONDON (Alliance News) - Shares in PuriCore PLC were trading up 12% Monday morning after it posted increased revenues in the third quarter ended September 30, boosted by large orders in its supermarket retail business.
PuriCore is a biotechnology company. Its shares were trading up 5.75 pence at 50.60p per share.
In a trading statement, PuriCore said that revenues in its third quarter were up 33% at USD14.6 million from USD11.0 million in the previous year. The company's Supermarket Retail and Wound Care and Dermatology businesses saw higher revenues than in the same period the previous year, PuriCore said, although its Endoscopy business saw reduced revenues due to the timing of capital installations in the UK National Health Service.
"We exceeded prior-year revenue for the comparable nine-month period and achieved particularly strong revenue growth during the third quarter, as expected, resulting primarily from our major supermarket orders in the US," said Chairman Michael Ashton in a statement.
The company said it is confident of its future prospects and would continue to advance its growth strategy as it made continued investments in its intellectual property portfolio, research and development and marketing.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Related Shares:
PURI.L